KDM5B and melanoma: Although this and additional factors (like JARID1B, NES, NGFR/CD271, SOX10, TDGF1/CRIPTO) have been proposed to mark melanoma CSC (reviewed in 13), the existence of CSC in melanoma tumors remains contentious.